BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7734758)

  • 1. The hidden effects of antihypertensive and lipid-lowering agents on the prevention and regression of atherogenesis: new management strategies.
    Weinberg MS
    R I Med; 1995 Mar; 78(3):78-81. PubMed ID: 7734758
    [No Abstract]   [Full Text] [Related]  

  • 2. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    Beevers DG; Lee KW; Lip GY
    J Hum Hypertens; 2003 Jun; 17(6):367-72. PubMed ID: 12764397
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive and lipid lowering treatment in stroke prevention: current state and future.
    Piechowski-Jóźwiak B; Bogousslavsky J
    Acta Neurol Belg; 2005 Jun; 105(2):57-61. PubMed ID: 16076057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking risks: primary prevention of cardiovascular events.
    Vallance P
    N Z Med J; 2001 May; 114(1132):223-4. PubMed ID: 11453356
    [No Abstract]   [Full Text] [Related]  

  • 5. ALLHAT: a saga of missed opportunities.
    McInnes GT
    J Hum Hypertens; 2003 Jun; 17(6):373-7. PubMed ID: 12764398
    [No Abstract]   [Full Text] [Related]  

  • 6. Basic approach to managing hyperglycemia for the nonendocrinologist.
    Deeg MA
    Am J Cardiol; 2005 Aug; 96(4A):37E-40E. PubMed ID: 16098842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New developments in the prevention and treatment of atherosclerosis, ischemic heart disease, hyperlipidemia and other diseases].
    Samsonov MA; Isaev VA
    Vopr Pitan; 1995; (4):33-4. PubMed ID: 7483479
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary revascularization and aggressive lipid lowering.
    Pershad A; Kratzer S; Cooper A
    J Invasive Cardiol; 1999 Feb; 11(2):87-9. PubMed ID: 10745488
    [No Abstract]   [Full Text] [Related]  

  • 9. [How can primary prevention of coronary heart disease be improved in general practice?].
    Wicklmayr M; Rett K; Standl E
    Med Klin (Munich); 1994 Apr; 89(4):184-6, 229. PubMed ID: 8015531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of arteriosclerosis.
    DePalma RG
    Compr Ther; 1992 Feb; 18(2):30-2. PubMed ID: 1547601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Editorial: hypertensiology].
    Hitzenberger G
    Wien Med Wochenschr; 2008; 158(13-14):357-8. PubMed ID: 18677584
    [No Abstract]   [Full Text] [Related]  

  • 12. Triggering of acute cardiovascular disease and potential preventive strategies.
    Tofler GH; Muller JE
    Circulation; 2006 Oct; 114(17):1863-72. PubMed ID: 17060396
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention and therapy of arteriosclerosis (author's transl)].
    Hauss WH
    Aktuelle Gerontol; 1978 Dec; 8(12):653-60. PubMed ID: 33560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALLHAT: definitive answers or continuing uncertainty?
    Sever P;
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):3-5. PubMed ID: 12692746
    [No Abstract]   [Full Text] [Related]  

  • 16. [Integrated drug therapy of the metabolic syndrome].
    Julius U; Hanefeld M
    Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
    Journath G; Hellénius ML; Petersson U; Theobald H; Nilsson PM;
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):258-62. PubMed ID: 18525379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors in adolescents: relevance, detection, and intervention.
    McCrindle BW
    Adolesc Med; 2001 Feb; 12(1):147-62. PubMed ID: 11224028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dyslipoproteinemias: treatment with lipid regulating drugs].
    Schwandt P
    Fortschr Med; 1990 Feb; 108(6):97-9. PubMed ID: 2323709
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipid anomalies during renal insufficiency: consequences on the progression of renal insufficiency and cardiovascular risk].
    Moulin B
    Nephrologie; 2000; 21(7):339-41. PubMed ID: 11200605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.